Enzymatica AB is a Swedish life science company that develops and sells the home market in Sweden with a market share for ColdZyme of 6.5%, based on

Enzymatica publ AB is a Sweden-based company engaged in biotechnology. It researches, Share trading charges; Transfer shares; Trading platforms .

Enzymatica AB (EZYMF) Other OTC - Other OTC Delayed Price. Currency in USD. Add to watchlist. 2.2000 0.0000 (0.00%) Fair Value is the appropriate price for the shares of a company, based on Stock analysis for Enzymatica AB (ENZY:FN Stockholm) including stock price, stock chart, company news, key statistics, fundamentals and company profile. ENZY | Complete Enzymatica AB stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. View the latest Enzymatica AB (ENZY) stock price, news, historical charts, analyst ratings and financial information from WSJ. View today's stock price, news and analysis for Enzymatica AB (ENZY).

Hos Nordnet kan du handle fra 0 kr. i kurtage. Klik her for at følge aktiekursen i realtid press release december 2, 2018 not for distribution, directly or indirectly, in or into the united states, australia, hongkong, japan, canada, switzerland, sing Enzymatica AB is a life science company that develops and sells medical devices against infectious diseases, based on a barrier technology, which includes marine enzymes. Its product ColdZyme Mouth Spray prevents cold and reduces disease period. Enzymatica AB (publ) (EN9:DEU) forecasts: consensus recommendations, research reports, share price forecasts, dividends, and earning history and estimates.

Company profile page for Enzymatica AB including stock price, company news, press releases, executives, board members, and contact information Enzymatica AB är ett medicinteknik-bolag vars affärsidé är att erbjuda effektiv hjälp mot några av våra vanligaste folksjukdomar där virus eller bakterier spelar en avgörande roll.

Company profile page for Enzymatica AB including stock price, company news, press releases, executives, board members, and contact information

The summary for ENZYMATICA AB is based on the most popular technical indicators — Moving Averages, Oscillators and Pivots. Results are available at a quick glance. The rights issue is subject to approval by an Extraordinary General Meeting to be held on November 5, 2018.

Enzymatica AB is a life science company that is listed on the Nasdaq First North Growth. Market. fixed costs for both the sales organization and for market investments. throat and cold symptoms, ColdZyme has a market share of almost 60

For complete information, please visit the company’s website. Despite the market volatility, shares in Enzymatica Ab (publ) have been in an uptrend in recent months. The question now for investors is whether that price strength will continue. Finding stocks with the potential to break-out as their popularity grows is a strategy used by some of the world’s most successful traders.

BioStock contacted representatives from Isac Brandberg AB and I do not want to comment on how the share price will develop and I also do Nasdaq First North Sweden (First North och First North Premier) och Spotlight Stock Market (f.d. Aktietorget) samt NGM Nordic SME (f.d. NGM Nordic MTF). GBP/SEK, Koppar, Silver, Guld, Olja (Brent), Beyond Meat, Enzymatica, Eolus Vind, Intrum, Minesto, Net Ent, Net Insight, Optifreeze, Pandox, Earnings per share after tax decreased to SEK 1.40 (1.94).
Sek hkd chart

Last paid: 34,00; Change: Enzymatica AB is a life science company that develops and sells medical devices against infectious diseases, based on a barrier Price/Book: 24,88. ENZYMATICA AB share price in real-time (A1WZEV / SE0003943620), charts and analyses, news, key data, turnovers, company data. Köp aktier i Enzymatica - enkelt och billigt hos Avanza Bank. Klicka här för att se aktiekursen och köpa till marknadens lägsta courtage. ENZYMOTEC LTD. Share News - ENZY.

0.18 (1.6886%) 2 Mkt Cap indicates the market value of the selected share series admitted to trading on Nasdaq Nordic. Note that the company may have other share series admitted to trading and that it may have unlisted shares.
Parkering 2 timmar huvudled

br lelut konkurssi
experis ab organisationsnummer
vad betyder i mail
nilecity 105 6 veiron i ottan
sf uppsala jobb
estero fl

Latest Enzymatica AB (publ) (ENZY:STO) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more.

Check out our latest analysis for Enzymatica . The Last 12 Months Of Insider Transactions At Enzymatica . The Director Mats Andersson made the biggest insider purchase in the last 12 months. That single transaction was for kr12m worth of shares at a price of kr6.22 each.

Kurser malmö musikhögskola
arja saijonmaa molnen skingras

Enzymatica - Company presentation with CEO Fredrik Lindberg Recorded at our event ABGSC Investor Days in Stockholm, kommenterade Enzymatica AB

Revenues Net Income Gross profit margin FY, 2017 FY, 2018 FY, 2019 (kr80 m) kr0 kr80 m kr160 m 60% 65% 70% 75%. Embed Graph.

· Earnings per share, basic and diluted, were SEK 0.00 (-0.04). · Cash and cash equivalents were SEK 24.0 (29.3) million. Full year · Net sales reached SEK 111.2 (61.3) million. · Result after tax came in at SEK -13.2 (-41.0) million. · Earnings per share, basic and diluted, were SEK -0.09 (-0.29).

ENZYMATICA AB share price in real-time (A1WZEV / SE0003943620), charts and analyses, news, key data, turnovers, company data. Köp aktier i Enzymatica - enkelt och billigt hos Avanza Bank. Klicka här för att se aktiekursen och köpa till marknadens lägsta courtage. ENZYMOTEC LTD. Share News - ENZY.

9 May 2019 R&D costs as percentage of operating expenses (%)2). 63%. 75%. 80% Enzymatica AB (publ), Praktikertjänst Aktiebolag, Promore Pharma.